Login / Signup

Potential candidate for oral pericoital contraception: evaluating ulipristal acetate plus cyclo-oxygenase-2 inhibitor for ovulation disruption.

Erica P CahillKlaira LermaKate A ShawPaul D Blumenthal
Published in: BMJ sexual & reproductive health (2022)
NCT03354117.
Keyphrases
  • polycystic ovary syndrome
  • human health
  • risk assessment
  • insulin resistance
  • climate change